World Wide relies on analytics signals to operate securely and keep research services available. Accept to continue, or leave the site.
Review the Privacy Policy for details about analytics processing.
Prof
Santa Fe Institute
Showing your local timezone
Schedule
Wednesday, October 7, 2020
5:00 PM Europe/London
Seminar location
No geocoded details are available for this content yet.
Recording provided by the organiser.
Format
Recorded Seminar
Recording
Available
Host
Analogical Minds
Seminar location
No geocoded details are available for this content yet.
In 1955, John McCarthy and colleagues proposed an AI summer research project with the following aim: “An attempt will be made to find how to make machines use language, form abstractions and concepts, solve kinds of problems now reserved for humans, and improve themselves.” More than six decades later, all of these research topics remain open and actively investigated in the AI community. While AI has made dramatic progress over the last decade in areas such as vision, natural language processing, and robotics, current AI systems still almost entirely lack the ability to form humanlike concepts and abstractions. Some cognitive scientists have proposed that analogy-making is a central mechanism for conceptual abstraction and understanding in humans. Douglas Hofstadter called analogy-making “the core of cognition”, and Hofstadter and co-author Emmanuel Sander noted, “Without concepts there can be no thought, and without analogies there can be no concepts.” In this talk I will reflect on the role played by analogy-making at all levels of intelligence, and on prospects for developing AI systems with humanlike abilities for abstraction and analogy.
Melanie Mitchell
Prof
Santa Fe Institute
neuro
neuro
The development of the iPS cell technology has revolutionized our ability to study development and diseases in defined in vitro cell culture systems. The talk will focus on Rett Syndrome and discuss t
neuro
Pluripotent cells, including embryonic stem (ES) and induced pluripotent stem (iPS) cells, are used to investigate the genetic and epigenetic underpinnings of human diseases such as Parkinson’s, Alzhe